Egrifta
- Product NDC
- 62064-041
- 11-digit product format
- 620640041
- Labeler code
- 62064
- Product ID
- 62064-041_a2509913-6b13-4c99-a0fe-b904078a2745
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tesamorelin
- Dosage form
- KIT
- Route
- SUBCUTANEOUS
- Labeler
- Theratechnologies Inc.
- Application
- NDA022505
- Marketing category
- NDA
- Marketing start
- 2019-07-01
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62064-041-30 | EA - Each | 62064-041 | 846d151e-71af-4e6b-899a-15bfe64524e5 | 1 | 2019-10-07 |